Developer docs
API playgroundTry for free, no card

Search company profiles

Xpeditemd, Inc.

Full company profile

uuid028wbva

Namestring
Xpeditemd, Inc.
Legal namestring
XpediteMD Inc.
Websiteurl
xpeditemd.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

XpediteMD, Inc. is a privately held, founder-led digital health company headquartered in Torrance, California, that has built an AI-powered cloud-based SaaS platform for oncology care navigation, clinical decision support, and billing enablement. The company sells primarily to U.S. oncology practices, health plans, and multi-provider medical groups, with a flagship partnership with SilverSummit Healthplan on breast cancer navigation (Project Accelerate).

The platform is organized around two product modules. XpediteMD Navigate™ is a unified patient navigation suite that ambiently captures navigation encounters via AI, tracks consents and clinical and social risk factors (including SDoH), and automatically maps encounters to oncology-specific CPT and HCPCS codes (PCM, PIN, CHI) based on navigator credentials to generate compliant billing documentation. XpediteMD Accelerate™ is a clinical decision support module for hospital systems and health plans that pre-qualifies guideline-based treatment pathways by cancer type and tumor characteristics, reducing prior authorization friction. The company markets outcomes including 77% reduction in biopsy-to-treatment time, 67% reduction in unnecessary prior authorizations, 95%+ guideline-compliant care, and $50,000+ in annual navigation revenue per provider.

XpediteMD operates as a SaaS subscription business with a direct enterprise field sales motion complemented by inside-sales demo capture, conference presence at ASBrS, ASTRO, and ACS Clinical Congress, an educational webinar program, and content marketing including a Navigation Revenue Calculator and billing guides. Pricing for the core navigation platform is sold via demo and is quote-based for enterprise contracts; the publicly listed Basic ($0), Pro ($199/month), and Enterprise ($399/month) tiers appear on the company website but reference an internal HR-management product rather than the navigation platform. The company is HIPAA compliant and PCI-DSS compliant via its payment processor, was founded in 2021 by Dennis R. Holmes, MD, FACS (Co-founder, CEO & CPO) and Artem Petrov (Head of Product), operates with 1–10 employees, and has no disclosed external institutional funding or parent company.

Short descriptiontext

XpediteMD is a U.S.-based, founder-led SaaS company that sells an AI-powered cloud platform for oncology patient navigation, ambient encounter documentation, and billable navigation revenue capture to oncology practices, health plans, and medical groups.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTorrance, United States
HQ citystring
Torrance
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology patient navigation, clinical decision support, cancer care coordination, oncology SaaS platform, navigation billing software
Industry4 codes
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAM
Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALABAF
Chronic Care & Remote Patient Monitoring (RPM) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services5415
SIC code2 codes
  • Services-Health Services8000
  • Services-Prepackaged Software7372
Product category
Oncology Patient Navigation Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

XpediteMD operates as a Software-as-a-Service platform offered at tiered pricing plans (Basic, Pro, Enterprise). The platform is offered as a cloud-based, integratable digital navigation and oncology care platform. Pricing is per user tier with up to 5 users (Free), 20 users ($199/month), or 50 users ($399/month).

xpeditemd.com
2Navigation Billing Revenue Generation
TypeSubscription Recurring
Description

The platform helps oncology practices generate revenue by enabling them to bill for patient navigation services using new CPT and HCPCS codes (PCM, PIN, CHI, SDOH). The company positions this as turning navigation from a cost center into a revenue stream, generating $50,000+ in annual revenue per provider for work already being performed.

xpeditemd.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Free plan for up to 5 users - basic features
ModelFreemiumBilling cadenceMonthly
Notes

Free plan includes basic HR management tools, attendance and leave management, and basic reporting. Manage up to 5 users with this plan.

xpeditemd.com
2Pro plan for up to 20 users
ModelSubscriptionBilling cadenceMonthly
Notes

$199 per month - Manage up to 20 users with this plan. Includes all Basic features plus expanded functionality.

xpeditemd.com
3Enterprise plan for up to 50 users
ModelSubscriptionBilling cadenceMonthly
Notes

$399 per month - Manage up to 50 users with this plan. Includes all Pro features plus enterprise-level capabilities.

xpeditemd.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1XpediteMD Navigate™
Description

AI-powered patient navigation product suite that organizes cancer navigation workflows, captures encounters in real time, and generates billing documentation.

xpeditemd.com
+1 more record
Core offering1 text field

XpediteMD provides an AI-powered, cloud-based SaaS platform that enables oncology practices to deliver patient navigation services. The platform combines ambient scribing of clinical encounters with oncology-specific clinical decision support and automated CPT/HCPCS code mapping so that navigation time and activities can be documented and billed under CMS and commercial-payer rules. The platform is sold as two suites — Navigate (patient navigation product suite) and Accelerate (clinical decision support module).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 77% reduction in biopsy-to-treatment time
+7 more records
Product overview1 text field

XpediteMD is an AI-powered oncology navigation platform offered as a cloud-based SaaS solution with two main product modules: XpediteMD Navigate™ (patient navigation product suite) and XpediteMD Accelerate™ (clinical decision support for health plans). The platform is designed for oncology practices, health plans, and medical groups. Navigate handles end-to-end patient navigation including encounter capture, documentation, and billing analytics, while Accelerate provides clinical decision support and order management for larger systems. The company also offers tiered pricing plans (Basic free, Pro at $199/month, Enterprise at $399/month) for different organization sizes.

Product and service2 records
1XpediteMD Navigate™
2XpediteMD Accelerate™
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Breast cancer navigation initiative (Project Accelerate) demonstrating measurable reductions in time to treatment after implementing XpediteMD navigation workflows. SilverSummit Healthplan publicly praised the collaboration, noting how XpediteMD helps breast cancer patients obtain care faster. The partnership has generated published outcomes and real-world evidence of platform effectiveness.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Oncology care management platform providing care navigation, symptom tracking, and nurse triage for community oncology. Comparable in patient navigation workflow automation and oncology-specific clinical decision support.

2Jvion
TypeEmerging player
Description

AI-driven clinical decision support and patient risk analytics platform across multiple conditions including oncology. Overlaps with XpediteMD Accelerate's guideline-based decision support capabilities.

TypeBroad incumbent
Description

Oncology-focused clinical decision support and care coordination platform offering evidence-based treatment pathways. Comparable in guideline-concordant care delivery and navigation; broader portfolio than XpediteMD.

TypeBroad incumbent
Description

Oncology-specific EHR and real-world data platform used by community oncology practices. Broader incumbent with practice-management depth and embedded decision support overlapping with XpediteMD's provider-facing modules.

5Tempus Labs
TypeBroad incumbent
Description

AI-enabled precision oncology platform combining clinical data, molecular profiling, and decision support. Larger, broader incumbent with adjacent oncology decision support but focused on molecular/therapeutic selection rather than navigation workflow.

TypeBroad incumbent
Description

Radiation therapy and oncology informatics provider offering treatment planning, software, and services. Adjacent incumbent in oncology clinical workflow and decision support across hospital systems.

7Carevive
TypeDirect peer
Description

Oncology care management and patient-reported outcomes platform serving cancer practices and life sciences. Directly comparable in oncology patient navigation, symptom monitoring, and care plan delivery.

TypeDirect peer
Description

Oncology-focused patient engagement and care navigation platform used by community oncology practices. Closest direct competitor, offering patient navigation, triage, and care plan tools overlapping directly with XpediteMD Navigate.

9McKesson (US Oncology Network)
TypeBroad incumbent
Description

Oncology services and distribution giant that acquired Navigating Cancer and operates US Oncology Network. Sets the bar for incumbent oncology care management and navigation deployment at scale.

TypeBroad incumbent
Description

Radiation oncology treatment planning and oncology workflow software incumbent (now part of Siemens Healthineers). Large incumbent addressing oncology care delivery and treatment pathways at hospital systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xpeditemd, Inc.

Oncology Patient Navigation Softwarexpeditemd.com

XpediteMD is a U.S.-based, founder-led SaaS company that sells an AI-powered cloud platform for oncology patient navigation, ambient encounter documentation, and billable navigation revenue capture to oncology practices, health plans, and medical groups.

What Xpeditemd, Inc. does

XpediteMD, Inc. is a privately held, founder-led digital health company headquartered in Torrance, California, that has built an AI-powered cloud-based SaaS platform for oncology care navigation, clinical decision support, and billing enablement. The company sells primarily to U.S. oncology practices, health plans, and multi-provider medical groups, with a flagship partnership with SilverSummit Healthplan on breast cancer navigation (Project Accelerate).

The platform is organized around two product modules. XpediteMD Navigate™ is a unified patient navigation suite that ambiently captures navigation encounters via AI, tracks consents and clinical and social risk factors (including SDoH), and automatically maps encounters to oncology-specific CPT and HCPCS codes (PCM, PIN, CHI) based on navigator credentials to generate compliant billing documentation. XpediteMD Accelerate™ is a clinical decision support module for hospital systems and health plans that pre-qualifies guideline-based treatment pathways by cancer type and tumor characteristics, reducing prior authorization friction. The company markets outcomes including 77% reduction in biopsy-to-treatment time, 67% reduction in unnecessary prior authorizations, 95%+ guideline-compliant care, and $50,000+ in annual navigation revenue per provider.

XpediteMD operates as a SaaS subscription business with a direct enterprise field sales motion complemented by inside-sales demo capture, conference presence at ASBrS, ASTRO, and ACS Clinical Congress, an educational webinar program, and content marketing including a Navigation Revenue Calculator and billing guides. Pricing for the core navigation platform is sold via demo and is quote-based for enterprise contracts; the publicly listed Basic ($0), Pro ($199/month), and Enterprise ($399/month) tiers appear on the company website but reference an internal HR-management product rather than the navigation platform. The company is HIPAA compliant and PCI-DSS compliant via its payment processor, was founded in 2021 by Dennis R. Holmes, MD, FACS (Co-founder, CEO & CPO) and Artem Petrov (Head of Product), operates with 1–10 employees, and has no disclosed external institutional funding or parent company.

Xpeditemd, Inc. firmographics

Firmographics
Name
Xpeditemd, Inc.
Legal name
XpediteMD Inc.
Website
https://xpeditemd.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
XpediteMD is a U.S.-based, founder-led SaaS company that sells an AI-powered cloud platform for oncology patient navigation, ambient encounter documentation, and billable navigation revenue capture to oncology practices, health plans, and medical groups.
Ownership category
akta.pro rank

Xpeditemd, Inc. industry classification

Industry
Product category
Oncology Patient Navigation Software
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (5415)
SIC
Services-Health Services (8000), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLACAPAM
Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALABAF
Chronic Care & Remote Patient Monitoring (RPM) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Oncology patient navigation
  • Clinical decision support
  • Cancer care coordination
  • Oncology SaaS platform
  • Navigation billing software

Where Xpeditemd, Inc. is headquartered

Location

Headquarters

HQ city
Torrance
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Xpeditemd, Inc. business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: XpediteMD operates as a Software-as-a-Service platform offered at tiered pricing plans (Basic, Pro, Enterprise). The platform is offered as a cloud-based, integratable digital navigation and oncology care platform. Pricing is per user tier with up to 5 users (Free), 20 users ($199/month), or 50 users ($399/month).
  2. Navigation Billing Revenue Generation: The platform helps oncology practices generate revenue by enabling them to bill for patient navigation services using new CPT and HCPCS codes (PCM, PIN, CHI, SDOH). The company positions this as turning navigation from a cost center into a revenue stream, generating $50,000+ in annual revenue per provider for work already being performed.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree plan for up to 5 users - basic features
SubscriptionMonthlyPro plan for up to 20 users
SubscriptionMonthlyEnterprise plan for up to 50 users

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Xpeditemd, Inc. product offering

Product offering

Core offering

XpediteMD provides an AI-powered, cloud-based SaaS platform that enables oncology practices to deliver patient navigation services. The platform combines ambient scribing of clinical encounters with oncology-specific clinical decision support and automated CPT/HCPCS code mapping so that navigation time and activities can be documented and billed under CMS and commercial-payer rules. The platform is sold as two suites — Navigate (patient navigation product suite) and Accelerate (clinical decision support module).

Product overview

XpediteMD is an AI-powered oncology navigation platform offered as a cloud-based SaaS solution with two main product modules: XpediteMD Navigate™ (patient navigation product suite) and XpediteMD Accelerate™ (clinical decision support for health plans). The platform is designed for oncology practices, health plans, and medical groups. Navigate handles end-to-end patient navigation including encounter capture, documentation, and billing analytics, while Accelerate provides clinical decision support and order management for larger systems. The company also offers tiered pricing plans (Basic free, Pro at $199/month, Enterprise at $399/month) for different organization sizes.

Differentiator

Problem solved

Functional benefit

Brands

  • XpediteMD Navigate™: AI-powered patient navigation product suite that organizes cancer navigation workflows, captures encounters in real time, and generates billing documentation.
  • XpediteMD Accelerate™

Products and services

  • XpediteMD Navigate™
  • XpediteMD Accelerate™

Quantifiable outcome

  • 77% reduction in biopsy-to-treatment time
  • +7 more outcomes

Companies that use Xpeditemd, Inc.

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Xpeditemd, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature8 records

Xpeditemd, Inc. partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SilverSummit HealthplancoreStrategic or Co-development Partner · 1 January 2025Breast cancer navigation initiative (Project Accelerate) demonstrating measurable reductions in time to treatment after implementing XpediteMD navigation workflows. SilverSummit Healthplan publicly praised the collaboration, noting how XpediteMD helps breast cancer patients obtain care faster. The partnership has generated published outcomes and real-world evidence of platform effectiveness.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Xpeditemd, Inc. competitors and assessment

Company assessment

Direct peers

  • Canopy: Oncology care management platform providing care navigation, symptom tracking, and nurse triage for community oncology. Comparable in patient navigation workflow automation and oncology-specific clinical decision support.
  • Carevive: Oncology care management and patient-reported outcomes platform serving cancer practices and life sciences. Directly comparable in oncology patient navigation, symptom monitoring, and care plan delivery.
  • Navigating Cancer: Oncology-focused patient engagement and care navigation platform used by community oncology practices. Closest direct competitor, offering patient navigation, triage, and care plan tools overlapping directly with XpediteMD Navigate.

Emerging players

  • Jvion: AI-driven clinical decision support and patient risk analytics platform across multiple conditions including oncology. Overlaps with XpediteMD Accelerate's guideline-based decision support capabilities.

Broad incumbents

  • NantHealth: Oncology-focused clinical decision support and care coordination platform offering evidence-based treatment pathways. Comparable in guideline-concordant care delivery and navigation; broader portfolio than XpediteMD.
  • Flatiron Health: Oncology-specific EHR and real-world data platform used by community oncology practices. Broader incumbent with practice-management depth and embedded decision support overlapping with XpediteMD's provider-facing modules.
  • Tempus Labs: AI-enabled precision oncology platform combining clinical data, molecular profiling, and decision support. Larger, broader incumbent with adjacent oncology decision support but focused on molecular/therapeutic selection rather than navigation workflow.
  • Elekta: Radiation therapy and oncology informatics provider offering treatment planning, software, and services. Adjacent incumbent in oncology clinical workflow and decision support across hospital systems.
  • McKesson (US Oncology Network): Oncology services and distribution giant that acquired Navigating Cancer and operates US Oncology Network. Sets the bar for incumbent oncology care management and navigation deployment at scale.
  • Varian (Siemens Healthineers): Radiation oncology treatment planning and oncology workflow software incumbent (now part of Siemens Healthineers). Large incumbent addressing oncology care delivery and treatment pathways at hospital systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Xpeditemd, Inc. social profiles

Digital presence

Xpeditemd, Inc. compliance and trust

Trust signal

Compliance2 records

Xpeditemd, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xpeditemd, Inc. leadership team

Management profile

Number of profiles

Profiles3 records

Xpeditemd, Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xpeditemd, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xpeditemd, Inc.

What does Xpeditemd, Inc. do?

XpediteMD provides an AI-powered, cloud-based SaaS platform that enables oncology practices to deliver patient navigation services. The platform combines ambient scribing of clinical encounters with oncology-specific clinical decision support and automated CPT/HCPCS code mapping so that navigation time and activities can be documented and billed under CMS and commercial-payer rules. The platform is sold as two suites — Navigate (patient navigation product suite) and Accelerate (clinical decision support module).

Is Xpeditemd, Inc. a public or private company?

Xpeditemd, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Xpeditemd, Inc. founded?

Xpeditemd, Inc. was founded in 2021. It employs 1 to 10 people.

Where is Xpeditemd, Inc. based?

Xpeditemd, Inc. is headquartered in Torrance, United States, in the North America region.

How does Xpeditemd, Inc. make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are navigation Billing Revenue Generation.

Who are Xpeditemd, Inc.'s main competitors?

Direct peers on record are Canopy, Carevive and Navigating Cancer. Jvion is listed as an emerging player. Broad incumbents are NantHealth, Flatiron Health, Tempus Labs, Elekta, McKesson (US Oncology Network) and Varian (Siemens Healthineers).

Does Xpeditemd, Inc. have an API?

No public API is recorded for Xpeditemd, Inc..

What industry is Xpeditemd, Inc. in?

Xpeditemd, Inc.'s product category is Oncology Patient Navigation Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 5132 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales